Drug-resistance inMycobacterium tuberculosis: where we stand-Reference-Cited by-同舟云学术

Drug-resistance inMycobacterium tuberculosis: where we stand

Published:2019 Issue:8 Volume:10 Page:1342-1360
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Mabhula Amanda¹²³⁴⁵,Singh Vinayak⁵⁶²³⁴^ORCID

Affiliation:

1. Department of Chemistry

2. University of Cape Town

3. Rondebosch 7701

4. South Africa

5. South African Medical Research Council Drug Discovery and Development Research Unit

6. Department of Chemistry and Institute of Infectious Disease and Molecular Medicine

Abstract

Tuberculosis (TB), an infectious disease caused by the bacteriumMycobacterium tuberculosis(Mtb), has burdened vulnerable populations in modern day societies for decades.

Funder

South African Medical Research Council

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/MD/C9MD00057G

Reference142 articles.

1. WHO , Global Tuberculosis Report World Health Organization , Geneva , 2018

2. HIV-1/ Mycobacterium tuberculosis Coinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis?

3. WHO , TB: A global health emergency , World Health Organization , Geneva , 1994

4. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular epidemiology of Mycobacterium tuberculosis in Ecuador: Recent advances and future challenges;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-12

2. Integrating computational and experimental approaches in discovery and validation of MmpL3 pore domain inhibitors for specific labelling of Mycobacterium tuberculosis;International Journal of Biological Macromolecules;2024-11

3. Antimicrobial resistance profile and prevalence of Mycobacterium tuberculosis complex in Western Iran using spoligotyping method;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-08

4. Tuberculosis treatment-shortening;Drug Discovery Today;2024-05

5. Novel strategies based on natural products and synthetic derivatives to overcome resistance in Mycobacterium tuberculosis;European Journal of Medicinal Chemistry;2024-04